Novo Nordisk Insulin

Novo Nordisk Insulin, including Tresiba Flextouch and Actrapid FlexPen, is essential in managing diabetes by regulating blood sugar levels. Tresiba Flextouch (insulin degludec) is a long-acting insulin with a chemical formula of C256H381N65O79S6, providing steady glucose control over 24+ hours. Actrapid FlexPen contains insulin regular, offering rapid glucose uptake for quick action. Both are formulated using advanced recombinant DNA technology, ensuring purity and efficacy. These insulins are packaged in user-friendly pens or vials for easy administration. Used in the healthcare industry, they significantly improve diabetic control, reducing complications and enhancing the patient's quality of life.